Last year, IDEXX Laboratories Inc generated 3.41B USD for its biggest-performing segment, CAG Diagnostics recurring revenue. The United States made the largest contribution, accounting for 2.75B USD last year. For the latest quarter, IDEXX Laboratories Inc reported the revenue of 974.71M USD for the period ending 2026-06-30, which came from the top-performing segment, CAG Diagnostics recurring revenue. United States contributed the highest revenue, at 772.97M USD.